Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 2

Status

Recruiting 3Terminated 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1Genitourinary 1

Conditions

Urinary Bladder, Neurogenic 1Urinary Bladder Neoplasms 1Urinary Bladder Diseases 1Small Cell Lung Carcinoma 1Neoplasms 1Malnutrition 1Gastrointestinal Neoplasms 1Esophagitis 1Endometriosis 1Cystitis, Interstitial 1Cystitis, Hemorrhagic 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1

Interventions

pembrolizumab 1282Specimen Handling 927Carboplatin 836Magnetic Resonance Spectroscopy 834Cyclophosphamide 807Cisplatin 735Nivolumab 680Paclitaxel 635Radiotherapy 617Gemcitabine 580Biopsy 559Bevacizumab 485Dexamethasone 444fludarabine 410Docetaxel 385venetoclax 372Oxaliplatin 367Capecitabine 361Fluorouracil 357atezolizumab 350durvalumab 340Rituximab 335Drug Therapy 333Radiosurgery 321Doxorubicin 319Blood Specimen Collection 317Standard of Care 311Pemetrexed 307Ipilimumab 303Radiation 287

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Immunonutrition Diet × 1 year × Clear all
NCT06840704 2026-04-02

Relief

Hunan Cancer Hospital

Phase 3 Recruiting
121 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Esophagitis, Small Cell Lung Carcinoma

NCT07395635 2026-02-09

Phase II Trial of Immunonutrition in Hepatectomy

Tata Memorial Centre

Phase NA Recruiting
100 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT01023412 2025-12-10

IPOD-3

Société des Produits Nestlé (SPN)

Phase NA Terminated
107 enrolled
Gastrointestinal

Gastrointestinal Neoplasms, Neoplasms

NCT05726786 2025-12-09

INCyst

Centre Hospitalier Universitaire Vaudois

Phase 3 Recruiting
232 enrolled
Genitourinary

Cystitis, Hemorrhagic, Urinary Bladder Diseases, Urinary Bladder Neoplasms, Urinary Bladder, Neurogenic, Endometriosis, Cystitis, Interstitial, Malnutrition

Data powered by HemOnc (CC BY 4.0) Colophon âš¡